Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension
Public ClinicalTrials.gov record NCT02178098. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 2 study will assess the efficacy and safety of ETC-1002 monotherapy versus placebo in participants with hypercholesterolemia and hypertension.
Study identification
- NCT ID
- NCT02178098
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 143 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 15, 2014
- Primary completion
- May 21, 2015
- Completion
- May 21, 2015
- Last update posted
- Apr 3, 2023
2014 – 2015
United States locations
- U.S. sites
- 43
- U.S. states
- 23
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35209 | — |
| Not listed | Muscle Shoals | Alabama | 35662 | — |
| Not listed | Chandler | Arizona | 85224 | — |
| Not listed | Glendale | Arizona | 85306 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | DeLand | Florida | 32720 | — |
| Not listed | Fort Lauderdale | Florida | 33306 | — |
| Not listed | Hialeah | Florida | 33012 | — |
| Not listed | Oviedo | Florida | 32765 | — |
| Not listed | Pembroke Pines | Florida | 33026 | — |
| Not listed | Pembroke Pines | Florida | 33029 | — |
| Not listed | Port Orange | Florida | 32127 | — |
| Not listed | Meridian | Idaho | 83646 | — |
| Not listed | Chicago | Illinois | 60607 | — |
| Not listed | Gurnee | Illinois | 60031 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Paducah | Kentucky | 42003 | — |
| Not listed | Auburn | Maine | 04210 | — |
| Not listed | Olive Branch | Mississippi | 38654 | — |
| Not listed | Butte | Montana | 59701 | — |
| Not listed | Las Vegas | Nevada | 89123 | — |
| Not listed | Berlin | New Jersey | 08009 | — |
| Not listed | Endwell | New York | 13760 | — |
| Not listed | Wilmington | North Carolina | 28401 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Cincinnati | Ohio | 45245 | — |
| Not listed | Cincinnati | Ohio | 45246 | — |
| Not listed | Lyndhurst | Ohio | 44124 | — |
| Not listed | Willoughby Hills | Ohio | 44094 | — |
| Not listed | Tulsa | Oklahoma | 74136 | — |
| Not listed | Eugene | Oregon | 97404 | — |
| Not listed | Downingtown | Pennsylvania | 19335 | — |
| Site 1 | Mt. Pleasant | South Carolina | 29464 | — |
| Site 2 | Mt. Pleasant | South Carolina | 29464 | — |
| Not listed | Simpsonville | South Carolina | 29681 | — |
| Not listed | Corpus Christi | Texas | 78404 | — |
| Not listed | Dallas | Texas | 75230 | — |
| Not listed | Dallas | Texas | 75234 | — |
| Not listed | Houston | Texas | 77036 | — |
| Not listed | Salt Lake City | Utah | 84107 | — |
| Not listed | Salt Lake City | Utah | 84124 | — |
| Not listed | Kenosha | Wisconsin | 53142 | — |
| Not listed | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02178098, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2023 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02178098 live on ClinicalTrials.gov.